Can AI Accelerate Clinical Review at FDA? - Pharmaceutical Executive
With reports that FDA's AI Elsa is “confidently hallucinating ” studies that don't exist, the use of AI to streamline drug review and speed up ...
Read the original at Pharmaceutical Executive ↗
- Topics
- Hallucinations & FabricationHealthcare
- Mentions
- FDA
- Tracked via
- “AI hallucination”